Pediatric Infectious Disease

Register      Login

VOLUME 6 , ISSUE 4 ( October-December, 2024 ) > List of Articles

CASE REPORT

Optimizing Treatment Strategies in a Pediatric Infectious Case: A Multidisciplinary Perspective

Komal R Mirlekar, Keyur D Mahajan, Sarika A Rakshe

Keywords : Case report, E. coli, Extended spectrum beta-lactamase, Mumps, Red man syndrome, Renal abscess, Urinary tract infection

Citation Information : Mirlekar KR, Mahajan KD, Rakshe SA. Optimizing Treatment Strategies in a Pediatric Infectious Case: A Multidisciplinary Perspective. Pediatr Inf Dis 2024; 6 (4):134-137.

DOI: 10.5005/jp-journals-10081-1430

License: CC BY-NC 4.0

Published Online: 05-11-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

This case study presents the comprehensive evaluation and management of a 4-year-old male patient with phimosis who presented with fever, anorexia, weakness, and burning micturition. Upon admission, bilateral multiple renal abscesses and cystitis were diagnosed through ultrasound examination, prompting initiation of intravenous (IV) piperacillin–tazobactam combination and IV vancomycin. Due to concerns of red man syndrome, vancomycin was closely monitored, and a multidisciplinary approach involving specialists in pediatric infectious diseases and surgery was adopted. Sensitivity testing revealed Escherichia coli infection resistant to multiple antibiotics, leading to a switch to IV meropenem. Additional investigations for suspected mumps yielded negative results, emphasizing the importance of thorough evaluation. The patient's condition improved with appropriate antibiotic therapy, as evidenced by decreasing abscess size and resolution of symptoms. This case underscores the significance of tailored antibiotic therapy, close monitoring, and multidisciplinary collaboration in managing complex pediatric infectious cases, ensuring optimal patient outcomes. Additionally, the patient's complete vaccination highlights the potential for atypical mumps presentations. Resurgence factors include secondary vaccine failure, reduced vaccine effectiveness (85–90%), and lack of natural boosting from wild-type virus.


HTML PDF Share
  1. Chen CY, Kuo HT, Chang YJ, et al. Clinical assessment of children with renal abscesses presenting to the pediatric emergency department. BMC Pediatr 2016;16(1):189. DOI: 10.1186/s12887-016-0732-5
  2. Baradkar VP, Mathur M, Kumar S. Renal abscess due to Escherichia coli in a child. Saudi J Kidney Dis Transpl 2011;22(6):1215–1218.
  3. Linder BJ, Granberg CF. Pediatric renal abscesses: a contemporary series. J Pediatr Urol 2016;12(2):99.e1–99.e5. DOI: 10.1016/j.jpurol.2015.05.037
  4. Capitán Manjón C, Tejido Sánchez A, Piedra Lara JD, et al. Retroperitoneal abscesses–analysis of a series of 66 cases. Scand J Urol Nephrol 2003;37(2):139–144. DOI: 10.1080/00365590310008884
  5. Mahajan KD, Joshi R. Evaluation of clinical spectrum, antibiotic sensitivity, and clinical outcome in pediatric age group (0–18 years) with extended-spectrum beta-lactamase-producing Escherichia coli-associated urinary tract infection in tertiary care hospital in India. Pediatr Infect Dis 2022;4:133–137. DOI: 10.5005/jp-journals-10081-1366
  6. Shaikh N, Morone NE, Bost JE, et al. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008;27(4):302–308. DOI: 10.1097/INF.0b013e31815e4122
  7. Desai DJ, Gilbert B, Mcbride CA. Paediatric urinary tract infections: diagnosis and treatment. Aust Fam Physician 2016;45(8):558–563.
  8. Moore CE, Sona S, Poda S, et al. Antimicrobial susceptibility of uropathogens isolated from Cambodian children. Paediatr Int Child Health 2016;36(2):113–117. DOI: 10.1179/2046905515Y.0000000008
  9. Kramer MS, Tange SM, Drummond KN, et al. Urine testing in young febrile children: a risk-benefit analysis. J Pediatr 1993;125(1):6–13. DOI: 10.1016/s0022-3476(94)70114-8
  10. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine 2009;27(44):6186–6195. DOI: 10.1016/j.vaccine.2009.06.109
  11. Rasheed MAU, Hickman CJ, McGrew M, et al. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood. Proc Natl Acad Sci U S A 2019;116(38):19071–19076. DOI: 10.1073/pnas.1905570116
  12. Hatchette T, Davidson R, Clay S, et al. Laboratory diagnosis of mumps in a partially immunized population: the Nova Scotia experience. Can J Infect Dis Med Microbiol 2009;20(4):e157–e162. DOI: 10.1155/2009/493275
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.